These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. Bansal S; Sahoo B; Garg V Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425 [TBL] [Abstract][Full Text] [Related]
3. Repigmentation of vitiligo macules treated topically with Efudix cream. Szekeres E; Morvay M Dermatologica; 1985; 171(1):55-9. PubMed ID: 4029463 [TBL] [Abstract][Full Text] [Related]
4. Depigmentation therapy for vitiligo in patients with Fitzpatrick skin type VI. Black W; Russell N; Cohen G Cutis; 2012 Feb; 89(2):57-60. PubMed ID: 22474725 [TBL] [Abstract][Full Text] [Related]
5. Flavonoids as adjuvant in psoralen based photochemotherapy in the management of vitiligo/leucoderma. Shivasaraun UV; Sureshkumar R; Karthika C; Puttappa N Med Hypotheses; 2018 Dec; 121():26-30. PubMed ID: 30396481 [TBL] [Abstract][Full Text] [Related]
6. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Schallreuter KU; Wood JM; Lemke KR; Levenig C Dermatology; 1995; 190(3):223-9. PubMed ID: 7599386 [TBL] [Abstract][Full Text] [Related]
7. PUVA treatment of vitiligo: a retrospective study of Turkish patients. Sahin S; Hindioğlu U; Karaduman A Int J Dermatol; 1999 Jul; 38(7):542-5. PubMed ID: 10440288 [TBL] [Abstract][Full Text] [Related]
8. The early repigmentation pattern of vitiligo is related to the source of melanocytes and by the choice of therapy: a retrospective cohort study. Yang K; Xiong X; Pallavi G; Ling Y; Ding F; Duan W; Sun W; Ding G; Gong Q; Zhu W; Lu Y Int J Dermatol; 2018 Mar; 57(3):324-331. PubMed ID: 29318595 [TBL] [Abstract][Full Text] [Related]
12. Acceleration of repigmentation in vitiligo by topical minoxidil in patients on photochemotherapy. Srinivas CR; Shenoi SD; Balachandran C Int J Dermatol; 1990 Mar; 29(2):154-5. PubMed ID: 2323875 [No Abstract] [Full Text] [Related]
13. Vitiligo: an update on current pharmacotherapy and future directions. Colucci R; Lotti T; Moretti S Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073 [TBL] [Abstract][Full Text] [Related]
14. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. Silverberg NB; Lin P; Travis L; Farley-Li J; Mancini AJ; Wagner AM; Chamlin SL; Paller AS J Am Acad Dermatol; 2004 Nov; 51(5):760-6. PubMed ID: 15523355 [TBL] [Abstract][Full Text] [Related]
15. An approach to the treatment of vitiligo by khellin. Abdel-Fattah A; Aboul-Enein MN; Wassel GM; El-Menshawi BS Dermatologica; 1982 Aug; 165(2):136-40. PubMed ID: 6754485 [TBL] [Abstract][Full Text] [Related]
16. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. Ortonne JP; Schmitt D; Thivolet J J Invest Dermatol; 1980 Jan; 74(1):40-2. PubMed ID: 7351492 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus-induced hyperpigmentation in a patch of vitiligo. De D; Kanwar AJ Skinmed; 2008; 7(2):93-4. PubMed ID: 18327009 [TBL] [Abstract][Full Text] [Related]
18. Treatment of vitiligo with khellin and ultraviolet A. Ortel B; Tanew A; Hönigsmann H J Am Acad Dermatol; 1988 Apr; 18(4 Pt 1):693-701. PubMed ID: 3270995 [TBL] [Abstract][Full Text] [Related]
19. Dermatitis produced by applications of monobenzone in patients with active vitiligo. Nordlund JJ; Forget B; Kirkwood J; Lerner AB Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053 [TBL] [Abstract][Full Text] [Related]
20. Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo. Lu-yan T; Wen-wen F; Lei-hong X; Yi J; Zhi-zhong Z Photodermatol Photoimmunol Photomed; 2006 Dec; 22(6):310-4. PubMed ID: 17100739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]